Finance

Lists
002566:SHE
Jilin Jian Yisheng Pharmaceutical Co Ltd
CNÂ¥6.85
+1.78%
(+0.12) 1D
Oct 16, 3:04:57 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002566...
Open
CNÂ¥6.78
High
CNÂ¥7.01
Low
CNÂ¥6.75
Mkt. cap
2.32B
Avg. vol.
6.78M
Volume
6.75M
Dividend
1.17%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
May 29, 2026
P/E ratio
61.16
52-wk high
CNÂ¥9.68
52-wk low
CNÂ¥5.76
EPS
CNÂ¥0.11
Shares outstanding
330.95M
No. of employees
2K
Open
CNÂ¥6.78
High
CNÂ¥7.01
Low
CNÂ¥6.75
Mkt. cap
2.32B
Avg. vol.
6.78M
Volume
6.75M
Dividend
1.17%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
May 29, 2026
P/E ratio
61.16
52-wk high
CNÂ¥9.68
52-wk low
CNÂ¥5.76
EPS
CNÂ¥0.11
Shares outstanding
330.95M
No. of employees
2K
News stories
From web sources and news partners
About Jilin Jian Yisheng Pharmaceutical Co Ltd
CEO-
Employees1.62K
FoundedJun 11, 1997
Headquarters-
SectorPharmaceutical industry
Websiteyisheng-pharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
148.37M
163.98M
178.61M
159.87M
Cost of goods sold
37.05M
51.97M
44.72M
40.73M
Cost of revenue
37.05M
51.97M
44.72M
40.73M
Research and development expenses
3.52M
3.58M
4.54M
4.01M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
97.33M
105.49M
115.30M
105.16M
Operating expense
110.81M
113.25M
125.70M
114.52M
Total operating expenses
147.86M
165.23M
170.42M
155.25M
Operating income
510.34K
-1.25M
8.19M
4.62M
Other non operating income
393.57K
-640.61K
-39.52K
46.60K
EBT including unusual items
5.35M
2.24M
18.90M
13.23M
EBT excluding unusual items
-2.30M
-2.76M
8.20M
10.96M
Income tax expense
756.21K
-2.27M
2.68M
1.62M
Effective tax rate
14.14%
-101.06%
14.18%
12.27%
Other operating expenses
9.69M
3.89M
3.88M
3.58M
Net income
5.36M
4.87M
16.14M
10.69M
Net profit margin
3.62%
2.97%
9.04%
6.68%
Earnings per share
-
-
-
-
Interest and investment income
194.61K
1.83M
3.14M
9.02M
Interest expense
-3.40M
-2.70M
-3.09M
-2.73M
Net interest expenses
-3.20M
-871.44K
55.92K
6.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
11.16M
8.38M
17.81M
14.24M
Gain or loss from assets sale
282.36K
-400.97K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps